These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7509088)
61. Antibody response to hepatitis C virus infection after liver transplantation. Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818 [TBL] [Abstract][Full Text] [Related]
62. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation. Candinas D; Joller-Jemelka HI; Schlumpf R; Wicki A; Mutimer DJ; Keusch G; Largiadèr F J Med Microbiol; 1994 Oct; 41(4):220-3. PubMed ID: 7523676 [TBL] [Abstract][Full Text] [Related]
63. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Niu MT; Alter MJ; Kristensen C; Margolis HS Am J Kidney Dis; 1992 Apr; 19(4):345-52. PubMed ID: 1562024 [TBL] [Abstract][Full Text] [Related]
64. HCV incidence in a dialysis center: preliminary reports. Ippolito E; Aterini S; Salvadori M; D'Elia G; Amato M Nephron; 1992; 61(3):375-6. PubMed ID: 1323797 [TBL] [Abstract][Full Text] [Related]
65. Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation. Ljungman P; Andersson J; Aschan J; Björkstrand B; Hägglund H; Lönnqvist B; Ringdén O; Winiarski J Clin Infect Dis; 1996 Jul; 23(1):167-9. PubMed ID: 8816147 [TBL] [Abstract][Full Text] [Related]
66. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372 [TBL] [Abstract][Full Text] [Related]
67. Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders. Gruber A; Norder H; Magnius L; Rotzén M; Rubio C; Grillner L; Björkholm M Ann Oncol; 1993 Mar; 4(3):229-34. PubMed ID: 7682437 [TBL] [Abstract][Full Text] [Related]
68. The lack of transmission of NANB/C hepatitis between acute and chronically infected patients and their heterosexual partners. Shev S; Wejstål R; Wahl M; Hermodsson S; Norkrans G Scand J Infect Dis; 1991; 23(4):407-11. PubMed ID: 1957126 [TBL] [Abstract][Full Text] [Related]
69. Hepatitis C in sickle cell anemia. DeVault KR; Friedman LS; Westerberg S; Martin P; Hosein B; Ballas SK J Clin Gastroenterol; 1994 Apr; 18(3):206-9. PubMed ID: 8034915 [TBL] [Abstract][Full Text] [Related]
70. [A preliminary study of HCV infections with hemophilia and their family members]. Sun HY; Li ZX; Liu WL; Xu HZ; Yang SH; Tang JZ; Hao LJ J Tongji Med Univ; 1994; 14(3):178-80. PubMed ID: 7528820 [TBL] [Abstract][Full Text] [Related]
71. Importance of recall and follow-up screening for chronic hepatitis C in children receiving blood products prior to 1990 in Japan. Matsuoka S; Tatara K; Ushiroguchi Y; Kubo M; Nii M; Taguchi Y; Kuroda Y Acta Paediatr Jpn; 1994 Aug; 36(4):383-6. PubMed ID: 7524266 [TBL] [Abstract][Full Text] [Related]
72. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G Blood; 1995 Aug; 86(4):1614-8. PubMed ID: 7632971 [TBL] [Abstract][Full Text] [Related]
74. Post-transfusion hepatitis C seroprevalence in Tanzanian children. Kitundu J; Msengi A; Matee M; Fataki M; Kazimoto T; Mpembeni R; Mnubhi E; Kalokola F Ann Trop Paediatr; 2001 Dec; 21(4):343-8. PubMed ID: 11732153 [TBL] [Abstract][Full Text] [Related]
75. Frequency of hepatitis C in acute post-transfusion hepatitis after open-heart surgery: a prospective study in 1,476 patients. Peters T; Schlayer HJ; Preisler S; Kopp B; Berthold H; Gerok W; Rasenack J J Med Virol; 1993 Feb; 39(2):139-45. PubMed ID: 7683711 [TBL] [Abstract][Full Text] [Related]
76. Presence of anti-hepatitis C virus serum markers in a dental school patient population. Shopper T; Boozer C; Lancaster D; Cade JE; Lundgren G Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 May; 79(5):655-60. PubMed ID: 7541304 [TBL] [Abstract][Full Text] [Related]
77. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Minola E; Prati D; Suter F; Maggiolo F; Caprioli F; Sonzogni A; Fraquelli M; Paggi S; Conte D Blood; 2002 Jun; 99(12):4588-91. PubMed ID: 12036892 [TBL] [Abstract][Full Text] [Related]
78. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. Fukuizumi K; Sata M; Suzuki H; Nakano H; Tanikawa K Scand J Infect Dis; 1997; 29(4):345-7. PubMed ID: 9360247 [TBL] [Abstract][Full Text] [Related]
79. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Locasciulli A; Testa M; Valsecchi MG; Vecchi L; Longoni D; Sparano P; Rovelli A; Uderzo C; Masera G; Alberti A Blood; 1997 Nov; 90(9):3799-805. PubMed ID: 9345068 [TBL] [Abstract][Full Text] [Related]